BRPI0412911A - lawsonia intracellularis de origem européia e vacinas, agentes de diagnóstico e métodos de uso da mesma - Google Patents

lawsonia intracellularis de origem européia e vacinas, agentes de diagnóstico e métodos de uso da mesma

Info

Publication number
BRPI0412911A
BRPI0412911A BRPI0412911-3A BRPI0412911A BRPI0412911A BR PI0412911 A BRPI0412911 A BR PI0412911A BR PI0412911 A BRPI0412911 A BR PI0412911A BR PI0412911 A BRPI0412911 A BR PI0412911A
Authority
BR
Brazil
Prior art keywords
intracellularis
european
vaccines
methods
diagnostic agents
Prior art date
Application number
BRPI0412911-3A
Other languages
English (en)
Inventor
Michael B Roof
Jeremy J Kroll
Jeffrey P Knittel
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34115340&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0412911(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of BRPI0412911A publication Critical patent/BRPI0412911A/pt
Publication of BRPI0412911B1 publication Critical patent/BRPI0412911B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/825—Bacterial vaccine for porcine species, e.g. swine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"LAWSONIA INTRACELLULARIS DE ORIGEM EUROPéIA E VACINAS, AGENTES DE DIAGNóSTICO E MéTODOS DE USO DA MESMA". A presente invenção refere-se a vacinas de L. intracellularis, e a métodos de proteção contra e diagnóstico de infecção de L. intracellularis. Os produtos e processos da invenção são alcançados, em parte, como resultado de um aperfeiçoado método de cultura em grande escala de L. intracellularis, incluindo um novo isolado de L. intracellularis de origem Européia e um método de preparação de um produto liofilizado contendo o isolado Europeu atenuado como um produto de vacina.
BRPI0412911A 2003-07-25 2004-07-15 "vacina para imunização de um animal e seu método de fabricação, método de cultivo de lawsonia intracellularis, método para o diagnóstico de enteropatia proliferativa em porcos" BRPI0412911B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49000103P 2003-07-25 2003-07-25
PCT/US2004/022704 WO2005011731A1 (en) 2003-07-25 2004-07-15 Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof

Publications (2)

Publication Number Publication Date
BRPI0412911A true BRPI0412911A (pt) 2006-09-26
BRPI0412911B1 BRPI0412911B1 (pt) 2020-01-21

Family

ID=34115340

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412911A BRPI0412911B1 (pt) 2003-07-25 2004-07-15 "vacina para imunização de um animal e seu método de fabricação, método de cultivo de lawsonia intracellularis, método para o diagnóstico de enteropatia proliferativa em porcos"

Country Status (23)

Country Link
US (2) US7312065B2 (pt)
EP (1) EP1651260B2 (pt)
JP (1) JP2006528882A (pt)
KR (1) KR101131845B1 (pt)
CN (2) CN1829529B (pt)
AT (1) ATE442163T2 (pt)
AU (1) AU2004260657B2 (pt)
BR (1) BRPI0412911B1 (pt)
CA (1) CA2533559C (pt)
CY (1) CY1109652T1 (pt)
DE (1) DE602004023094D1 (pt)
DK (1) DK1651260T4 (pt)
ES (1) ES2333334T5 (pt)
MX (1) MXPA06000994A (pt)
MY (1) MY140208A (pt)
PL (1) PL1651260T5 (pt)
PT (1) PT1651260E (pt)
RU (1) RU2420570C2 (pt)
SG (1) SG144909A1 (pt)
SI (1) SI1651260T2 (pt)
UA (1) UA87665C2 (pt)
WO (1) WO2005011731A1 (pt)
ZA (1) ZA200510081B (pt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772047B1 (fr) * 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US8834891B2 (en) * 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
AU2012207016B2 (en) * 2005-03-14 2015-01-15 Boehringer Ingelheim Animal Health USA Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
MX338626B (es) 2005-12-29 2016-04-26 Boehringer Ingelheim Vetmed Uso de una composicion inmunogenica de pcv2 para producir los sintomas clinicos en cerdos.
EP2275132B1 (en) 2005-12-29 2021-03-03 Boehringer Ingelheim Animal Health USA Inc. Multivalent PCV2 immunogenic compositions and methods of producing them
US8470336B2 (en) * 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
US20080241190A1 (en) * 2006-11-13 2008-10-02 Boehringer Ingelheim Vetmedica, Inc. Vaccination of horses against lawsonia intracellularis
EP2099927A4 (en) * 2006-11-22 2010-05-05 Boehringer Ingelheim Vetmed Methods of reducing porcine circovirus-associated disease outbreaks
EP2859900A1 (en) 2006-12-11 2015-04-15 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
BRPI0721083A2 (pt) * 2006-12-15 2014-02-25 Boehringer Ingelheim Vetmed Tratamento de porcos com antígeno de pcv2
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) * 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
TW200918666A (en) * 2007-09-11 2009-05-01 Wyeth Corp Attenuated mycoplasma gallisepticum strains
EP2200643B1 (en) 2007-09-17 2013-09-04 Boehringer Ingelheim Vetmedica, Inc. A live lawsonia intracellularis vaccine administered in combination with an antibiotic for use in the treatment of lawsonia intracellularis infections in pigs
JP2011508595A (ja) * 2007-12-31 2011-03-17 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド 外来性アミノ酸の挿入を含むｐｃｖ２ｏｒｆ２ウイルス様粒子
JP5613061B2 (ja) * 2008-01-23 2014-10-22 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド Ｐｃｖ２マイコプラズマ・ハイオニューモニエ免疫原性組成物および前記組成物の製造方法
US20110033495A1 (en) * 2008-02-15 2011-02-10 Boehringer Ingelheim Vetmedica, Inc. Methods and compositions for reducing the impact of enteric diseases
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
TWI449533B (zh) 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
ES2534556T3 (es) * 2008-07-22 2015-04-24 Intervet International Bv Bacteria Lawsonia intracellularis de un nuevo serotipo, vacuna basada en esa bacteria, anticuerpos adecuados para diagnosticar el nuevo serotipo de Lawsonia intracellularis e hibridomas para producir dichos anticuerpos
US8142760B2 (en) * 2008-09-05 2012-03-27 Nathan Len Winkelman Vaccination for Lawsonia intracellularis
WO2011006880A1 (en) * 2009-07-14 2011-01-20 Intervet International B.V. Lawsonia intracellularis propagation
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
EP2499233B1 (en) 2009-11-09 2016-11-02 Intervet International B.V. Method to grow lawsonia intracellularis bacteria in persistently infected mccoy cells
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
SMT201800284T1 (it) 2011-06-10 2018-07-17 Univ Oregon Health & Science Glicoproteine cmv e vettori ricombinanti
KR102319843B1 (ko) 2013-09-25 2021-10-29 조에티스 서비시즈 엘엘씨 Pcv2b 분지형 백신 조성물 및 사용 방법
US9505808B2 (en) 2013-10-02 2016-11-29 Boehringer Ingelheim Vetmedica, Inc. PCV2 ORF2 protein variant and virus like particles composed thereof
EP3076995B1 (en) 2013-12-03 2020-03-11 Intervet International B.V. Vaccine against lawsonia intracellularis and porcine circovirus 2
CN103823063B (zh) * 2014-02-25 2015-09-30 上海理工大学 检测猪霍乱沙门氏菌的方法及其单抗
EP3253410B1 (en) 2015-02-04 2020-05-06 Intervet International B.V. A vaccine for use against subclinical lawsonia infection in a pig
KR101893827B1 (ko) * 2016-01-04 2018-08-31 전북대학교 산학협력단 약독화된 살모넬라 변이주를 유효성분으로 포함하는 돼지 증식성 회장염 및 살모넬라증 동시 예방 또는 치료용 백신 조성물
JP7139437B2 (ja) * 2018-02-28 2022-09-20 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー 動物内のスカトール及び／又はインドールの低減方法
KR102249189B1 (ko) * 2020-01-09 2021-05-07 전북대학교 산학협력단 항원성이 증진된 항원을 발현하는 약독화된 살모넬라 변이주를 유효성분으로 포함하는 돼지 증식성 회장염 및 살모넬라증 동시 예방 또는 치료용 백신 조성물
CA3185751A1 (en) * 2020-07-24 2022-01-27 Edgar DIAZ Combination porcine vaccine
CN111961627A (zh) * 2020-08-27 2020-11-20 南京农业大学 一种胞内劳森菌的分离与培养方法
WO2023073640A1 (en) 2021-11-01 2023-05-04 Boehringer Ingelheim Vetmedica Gmbh Immunogenic gel compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714375A (en) 1995-06-05 1998-02-03 Nobl Laboratories, Inc. Ileal symbiont intracellularis propagation in suspended host cells
US5885823A (en) * 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents

Also Published As

Publication number Publication date
US7312065B2 (en) 2007-12-25
US20080112980A1 (en) 2008-05-15
PT1651260E (pt) 2009-09-24
SI1651260T1 (sl) 2010-01-29
JP2006528882A (ja) 2006-12-28
ZA200510081B (en) 2006-08-30
EP1651260B2 (en) 2018-06-27
MXPA06000994A (es) 2006-05-15
RU2006105715A (ru) 2007-09-10
ES2333334T5 (es) 2018-08-06
EP1651260A1 (en) 2006-05-03
EP1651260B1 (en) 2009-09-09
CA2533559C (en) 2013-07-02
ES2333334T3 (es) 2010-02-19
US7758870B2 (en) 2010-07-20
DK1651260T4 (en) 2018-10-08
KR20060054352A (ko) 2006-05-22
US20050031647A1 (en) 2005-02-10
KR101131845B1 (ko) 2012-03-30
AU2004260657A1 (en) 2005-02-10
CN101423811A (zh) 2009-05-06
SI1651260T2 (sl) 2018-09-28
CN1829529A (zh) 2006-09-06
AU2004260657B2 (en) 2012-06-07
DK1651260T3 (da) 2010-01-11
PL1651260T5 (pl) 2018-11-30
RU2420570C2 (ru) 2011-06-10
CA2533559A1 (en) 2005-02-10
BRPI0412911B1 (pt) 2020-01-21
WO2005011731A1 (en) 2005-02-10
DE602004023094D1 (de) 2009-10-22
SG144909A1 (en) 2008-08-28
UA87665C2 (ru) 2009-08-10
CN1829529B (zh) 2011-05-04
MY140208A (en) 2009-11-30
PL1651260T3 (pl) 2010-02-26
CY1109652T1 (el) 2014-08-13
ATE442163T2 (de) 2009-09-15

Similar Documents

Publication Publication Date Title
DE602004023094D1 (de) Lawsonia intracellularis europäischen ursprungs unür
MY180698A (en) Immunization protocol against the 4 dengue serotypes
BRPI0620193B8 (pt) composição imunogênica e vacina a compreendendo, bem como processo para preparar a vacina
WO2005116270A3 (en) Influenza virus vaccine composition and method of use
FR13C0040I2 (fr) Vaccins polypeptidiques offrant une large protection contre des lignees de meningocoques hypervirulentes
BRPI0813307B8 (pt) composição imunogênica, vacina, e, processo para fabricar a vacina
ES2156110T3 (es) Analogos de sub-unidades de toxina del colera derivados de adn recombinante.
MX2010005014A (es) Vacuna viva avirulenta de mycoplasma hyopneumoniae con adyuvante.
MX2010012999A (es) Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso.
MX2012003827A (es) Toxina rtx citolitica de gallibacterium anatis.
ATE386541T1 (de) Neisseria impfstoffzusammensetzungen und methoden
DK1796717T3 (da) Kombinationsvaccine
TW200502384A (en) Live attenuated bacteria of the species actinobacillus pleuropneumoniae
WO2007135420A3 (en) Defective interfering virus
SE9903534D0 (sv) Vaccin
NZ598459A (en) Adjuvant comprising aluminium, oligonucleotide and polycation
ATE353223T1 (de) Multi-komponenten impfstoff zum schutz vor krankheiten die durch haemophilus influenza und moxarella catarrhalis ausgelöst werden
YU99603A (sh) Geni koji su povezani sa virulencijom parazita laišmanije
TW200510524A (en) Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
PH12022550261A1 (en) Methods for preventing dengue and hepatitis a
WO2009030676A3 (en) Pharmaceutical composition comprising a japanese encephalitis virus for vaccination of patients of at least 40 years of age
Bhattacharya et al. A sudden increase in occurrence of salmonella paratyphi a infection in rourkela, western odisha
US11065321B2 (en) Live attenuated bacterial strain and its use as a vaccine
JO3420B1 (ar) تركيبة صيدلانية ولقاح للوقاية من اصابات المكورة العقدية

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O ARTIGO 8O C/C 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/01/2020, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved

Owner name: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. (US)

B25G Requested change of headquarter approved

Owner name: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. (US)